Rate of early hospital readmission amongst cirrhotic patients is high in Australia: experience from a single liver transplant centre

The 30‐day hospital readmission rate in cirrhotic patients has been demonstrated to be up to 40% in international studies, but is not well studied in Australia. The aim of the current study was to report on the rate and cause of 30‐day hospital readmission from a single liver transplant referral centre, including a cost analysis of readmissions.

[1]  W. Kim,et al.  Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021 .

[2]  P. Kamath,et al.  Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database , 2021, Annals of translational medicine.

[3]  K. Reddy,et al.  The Evolving Challenge of Infections in Cirrhosis. , 2021, The New England journal of medicine.

[4]  L. Celi,et al.  Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis , 2020, Journal of gastroenterology and hepatology.

[5]  S. Saab,et al.  Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults , 2020, JAMA network open.

[6]  P. Kamath,et al.  Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project , 2020, Hepatology.

[7]  R. Wong,et al.  Hepatic Encephalopathy is a Strong Predictor of Early Hospital Readmission Among Cirrhosis Patients. , 2019, Journal of clinical and experimental hepatology.

[8]  S. McPhail,et al.  Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians , 2019, EClinicalMedicine.

[9]  Alice E. Huang,et al.  Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge , 2019, The American journal of gastroenterology.

[10]  Nejm Catalyst.  Hospital Readmissions Reduction Program (HRRP) , 2018 .

[11]  N. Chalasani,et al.  Hospital Readmissions in Patients with Cirrhosis: A Systematic Review , 2018, Journal of hospital medicine.

[12]  E. Tapper,et al.  Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  K. Reddy,et al.  The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis , 2016, Hepatology.

[14]  T. Spelman,et al.  Could Adherence to Quality of Care Indicators for Hospitalized Patients With Cirrhosis-Related Ascites Improve Clinical Outcomes? , 2016, The American Journal of Gastroenterology.

[15]  S. McPhail,et al.  Burden of decompensated cirrhosis and ascites on hospital services in a tertiary care facility: time for change? , 2014, Internal medicine journal.

[16]  Michael L Volk,et al.  Hospital Readmissions Among Patients With Decompensated Cirrhosis , 2012, The American Journal of Gastroenterology.

[17]  James Nguyen,et al.  Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  S. Møller.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. , 2010, Journal of hepatology.

[19]  Phillip S. Ge,et al.  Treatment of Patients with Cirrhosis. , 2016, The New England journal of medicine.

[20]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[21]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.